Abstract: This is a case report about Porphyria cutanea tarda (PCT) and its relationship with the infection caused by the human immunodeficiency virus (HIV). Cutaneous porphyria is an illness caused by enzymatic modification that results in partial deficiency of uroporphyrinogen decarboxylase (Urod), which may be hereditary or acquired. Several studies suggest that HIV infection associated with cofactors might trigger the development of porphyria cutanea tarda. In this case report, we present a patient infected with HIV, who after the introduction of antiretroviral therapy (ART) enjoyed clinical improvement of porphyria cutanea tarda symptoms.
INTRODUCTION
Porphyrias are rare metabolic disorders which are characterized by an abnormality in the biosynthesis of heme complex by erythrocytes, due to an enzymatic deficiency in the production of porphyrin precursors. [1] [2] [3] They can divided into four types, according to their characteristics. The sporadic form (Type I), also named "acquired", is char- PCT usually affects middle-aged individuals, over 40 years old. 1 The disease has as main triggering factors: alcohol, iron, estrogen, hepatitis C virus (HCV), human immunodeficiency virus (HIV), polychlorinated hydrocarbons and hemodialysis/chronic renal failure (CRF). 3, 5 The interest in reporting this PCT case is based on the rarity of the disease and questioning HIV as the only triggering factor. The deposition of porphyrins in the skin causes cutaneous photo-sensitization, because they are unable to store energy from light, which is released to the skin as a photochemical reaction, causing cutaneous damage. 3, 4 Clinical manifestations are: skin fragility, vesicles and bullae (tense, with hyaline content), followed by erosion and crusts, which occur mainly in areas exposed to the sun and trauma areas, such as face and back of hands and feet. Hyperpigmentation of areas exposed to the sun may occur. There can still be hypertrichosis, FIgure 1: Ulcerated lesions and miliary atrophic scars on the nose, lips and forehead region. Ulcerated ruptured bullae on the pinna and bullae with citrine yellow content on the fingers The physiopathology of PCT and HIV association is not totally understood, however the authors suggest that HIV carriers have altered steroid metabolism, which increases the production of endogenous estrogen and, consequently, interferes in the synthesis of heme, causing PCT. HIV infection is the cause of abnormal excretion of porphyrins, even with no clinical evidence of PCT. 1, 9 Some studies suggest that PCT may be caused by ART. 3, 4 On the other hand, other studies report improvement of patients after the start of ART. 7, 10 Treatment consists of identification and elimination of the causing factor. Phlebotomy could be performed weekly, collecting 500 ml per session, until hemoglobin reaches a level lower than 10 g/dl, or serum iron reaches 50 g/dl to 60 g/dl or less, or even porphyrins in the urine reach a level lower than 400 μg. Oral chloroquine therapy is also used, twice a week, at low doses (125 mg to 250 mg). Cimetidine is also described as a therapeutic option for PCT, at 800 mg/day. 3 HIV may play an independent role in causing PCT. Of all known risk factors, HIV was the only one present in the reported case. After the reintroduction and correct use of ART (its use was irregular), there was clinical remission of the disease, which also suggests that HIV and high levels of viral replication may be direct inducers of PCT.q
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